Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome

The study investigated the association between disease activity and serum 25-hydroxyvitamin D3 (25(OH)-D3), B cell activation of the tumor necrosis factor family (BAFF), or β2 microglobulin in patients with primary Sjogren’s syndrome (SS). Sixty-nine primary SS patients and 22 sicca control patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Sang Jin Lee, Hye Jin Oh, Byoong Yong Choi, Yu Jin Jang, Joo Youn Lee, Jin Kyun Park, Yeong Wook Song
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2016/5781070
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162568562212864
author Sang Jin Lee
Hye Jin Oh
Byoong Yong Choi
Yu Jin Jang
Joo Youn Lee
Jin Kyun Park
Yeong Wook Song
author_facet Sang Jin Lee
Hye Jin Oh
Byoong Yong Choi
Yu Jin Jang
Joo Youn Lee
Jin Kyun Park
Yeong Wook Song
author_sort Sang Jin Lee
collection DOAJ
description The study investigated the association between disease activity and serum 25-hydroxyvitamin D3 (25(OH)-D3), B cell activation of the tumor necrosis factor family (BAFF), or β2 microglobulin in patients with primary Sjogren’s syndrome (SS). Sixty-nine primary SS patients and 22 sicca control patients were included in the study. Disease activity was measured with EULAR Sjogren’s syndrome disease activity index (ESSDAI). Serum levels of 25(OH)-D3 and β2 microglobulin were measured by radioimmunoassay and BAFF was measured by an enzyme-linked immunosorbent assay. Serum levels of 25(OH)-D3 were significantly lower in SS patients compared to the sicca controls (p=0.036). Serum levels of BAFF tended to be higher (p=0.225) and those of β2 microglobulin were significantly higher in patients with SS than in sicca controls (p=0.023). In univariate regression analyses, ESSDAI was significantly associated with serum levels of 25(OH)-D3, BAFF, and β2 microglobulin. After stepwise backward multivariate linear regression analyses including age and acute phase reactants, ESSDAI was associated with 25(OH)-D3 (β = −0.042, p=0.015) and BAFF (β = 0.001, p=0.015) in SS patients. In SS patients, ESSDAI is negatively associated with serum levels of 25(OH)-D3 and positively associated with BAFF.
format Article
id doaj-art-fe291f2cab384562aefaa174319f435b
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-fe291f2cab384562aefaa174319f435b2025-08-20T02:22:32ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/57810705781070Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s SyndromeSang Jin Lee0Hye Jin Oh1Byoong Yong Choi2Yu Jin Jang3Joo Youn Lee4Jin Kyun Park5Yeong Wook Song6Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Seoul Medical Center, Seoul, Republic of KoreaDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Medical Research Center, Seoul National University, Seoul, Republic of KoreaDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Medical Research Center, Seoul National University, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of KoreaThe study investigated the association between disease activity and serum 25-hydroxyvitamin D3 (25(OH)-D3), B cell activation of the tumor necrosis factor family (BAFF), or β2 microglobulin in patients with primary Sjogren’s syndrome (SS). Sixty-nine primary SS patients and 22 sicca control patients were included in the study. Disease activity was measured with EULAR Sjogren’s syndrome disease activity index (ESSDAI). Serum levels of 25(OH)-D3 and β2 microglobulin were measured by radioimmunoassay and BAFF was measured by an enzyme-linked immunosorbent assay. Serum levels of 25(OH)-D3 were significantly lower in SS patients compared to the sicca controls (p=0.036). Serum levels of BAFF tended to be higher (p=0.225) and those of β2 microglobulin were significantly higher in patients with SS than in sicca controls (p=0.023). In univariate regression analyses, ESSDAI was significantly associated with serum levels of 25(OH)-D3, BAFF, and β2 microglobulin. After stepwise backward multivariate linear regression analyses including age and acute phase reactants, ESSDAI was associated with 25(OH)-D3 (β = −0.042, p=0.015) and BAFF (β = 0.001, p=0.015) in SS patients. In SS patients, ESSDAI is negatively associated with serum levels of 25(OH)-D3 and positively associated with BAFF.http://dx.doi.org/10.1155/2016/5781070
spellingShingle Sang Jin Lee
Hye Jin Oh
Byoong Yong Choi
Yu Jin Jang
Joo Youn Lee
Jin Kyun Park
Yeong Wook Song
Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
Journal of Immunology Research
title Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
title_full Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
title_fullStr Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
title_full_unstemmed Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
title_short Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome
title_sort serum 25 hydroxyvitamin d3 and baff levels are associated with disease activity in primary sjogren s syndrome
url http://dx.doi.org/10.1155/2016/5781070
work_keys_str_mv AT sangjinlee serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
AT hyejinoh serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
AT byoongyongchoi serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
AT yujinjang serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
AT jooyounlee serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
AT jinkyunpark serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
AT yeongwooksong serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome